These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10637570)

  • 1. Causes and consequences of tumour acidity and implications for treatment.
    Stubbs M; McSheehy PM; Griffiths JR; Bashford CL
    Mol Med Today; 2000 Jan; 6(1):15-9. PubMed ID: 10637570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.
    El-Kenawi A; Gatenbee C; Robertson-Tessi M; Bravo R; Dhillon J; Balagurunathan Y; Berglund A; Vishvakarma N; Ibrahim-Hashim A; Choi J; Luddy K; Gatenby R; Pilon-Thomas S; Anderson A; Ruffell B; Gillies R
    Br J Cancer; 2019 Oct; 121(7):556-566. PubMed ID: 31417189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severely polarized extracellular acidity around tumour cells.
    Feng Q; Bennett Z; Grichuk A; Pantoja R; Huang T; Faubert B; Huang G; Chen M; DeBerardinis RJ; Sumer BD; Gao J
    Nat Biomed Eng; 2024 Jun; 8(6):787-799. PubMed ID: 38438799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid pH in tumors and its potential for therapeutic exploitation.
    Tannock IF; Rotin D
    Cancer Res; 1989 Aug; 49(16):4373-84. PubMed ID: 2545340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modelling of tumour acidity: regulation of intracellular pH.
    Webb SD; Sherratt JA; Fish RG
    J Theor Biol; 1999 Jan; 196(2):237-50. PubMed ID: 9990741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes and consequences of acidic pH in tumors: a magnetic resonance study.
    Stubbs M; McSheehy PM; Griffiths JR
    Adv Enzyme Regul; 1999; 39():13-30. PubMed ID: 10470364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironmental and cellular consequences of altered blood flow in tumours.
    Raghunand N; Gatenby RA; Gillies RJ
    Br J Radiol; 2003; 76 Spec No 1():S11-22. PubMed ID: 15456710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling tumour acidity and invasion.
    Webb SD; Sherratt JA; Fish RG
    Novartis Found Symp; 2001; 240():169-81; discussion 181-5. PubMed ID: 11727928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment.
    Dumas JF; Brisson L; Chevalier S; Mahéo K; Fromont G; Moussata D; Besson P; Roger S
    Semin Cancer Biol; 2017 Apr; 43():90-110. PubMed ID: 28323020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase.
    Yamagata M; Hasuda K; Stamato T; Tannock IF
    Br J Cancer; 1998 Jun; 77(11):1726-31. PubMed ID: 9667639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
    Choi SY; Collins CC; Gout PW; Wang Y
    J Pathol; 2013 Aug; 230(4):350-5. PubMed ID: 23729358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rationale for the use of proton pump inhibitors as antineoplastic agents.
    De Milito A; Marino ML; Fais S
    Curr Pharm Des; 2012; 18(10):1395-406. PubMed ID: 22360553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics.
    McSheehy PM; Troy H; Kelland LR; Judson IR; Leach MO; Griffiths JR
    Eur J Cancer; 2003 Mar; 39(4):532-40. PubMed ID: 12751386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model.
    Webb SD; Sherratt JA; Fish RG
    Clin Exp Metastasis; 1999 Jul; 17(5):397-407. PubMed ID: 10651306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.
    Yamagata M; Tannock IF
    Br J Cancer; 1996 Jun; 73(11):1328-34. PubMed ID: 8645575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature.
    Kaznatcheev A; Vander Velde R; Scott JG; Basanta D
    Br J Cancer; 2017 Mar; 116(6):785-792. PubMed ID: 28183139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular pH distribution in human tumours.
    Engin K; Leeper DB; Cater JR; Thistlethwaite AJ; Tupchong L; McFarlane JD
    Int J Hyperthermia; 1995; 11(2):211-6. PubMed ID: 7790735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical models of tumour invasion mediated by transformation-induced alteration of microenvironmental pH.
    Gatenby RA; Gawlinski ET
    Novartis Found Symp; 2001; 240():85-96; discussion 96-9. PubMed ID: 11727939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tumour intracellular pH: a mathematical model examining the interplay between H+ and lactate.
    Al-Husari M; Webb SD
    J Theor Biol; 2013 Apr; 322():58-71. PubMed ID: 23340437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cellular automaton model examining the effects of oxygen, hydrogen ions and lactate on early tumour growth.
    Al-Husari M; Murdoch C; Webb SD
    J Math Biol; 2014 Oct; 69(4):839-73. PubMed ID: 23982261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.